期刊
FUTURE MEDICINAL CHEMISTRY
卷 9, 期 7, 页码 673-691出版社
FUTURE SCI LTD
DOI: 10.4155/fmc-2017-0007
关键词
antibiotics; bacterial resistance; metalloenzymes
资金
- Australian Research Council
- National Health and Medical Research Council
The global overuse of antibiotics has led to the emergence of drug-resistant pathogenic bacteria. Bacteria can combat beta-lactams by expressing beta-lactamases. Inhibitors of one class of beta-lactamase, the serine-beta-lactamases, are used clinically to prevent degradation of beta-lactam antibiotics. However, a second class of beta-lactamase, the metallo-beta-lactamases (MBLs), function by a different mechanism to serine-beta-lactamases and no inhibitors of MBLs have progressed to be used in the clinic. Bacteria that express MBLs are an increasingly important threat to human health. This review outlines various approaches taken to discover MBL inhibitors, with an emphasis on the different chemical classes of inhibitors. Recent progress, particularly new screening methods and the rational design of potent MBL inhibitors are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据